Skip to main content
. 2019 Jun 19;3(3):pkz042. doi: 10.1093/jncics/pkz042

Figure 4.

Figure 4.

Associations between the presence of preoperative circulating tumor DNA and clinicopathological variables and oncologic outcomes. The percentage of patients with a positive marker is represented for the categories of the variables. Green: all studies reporting on the specific marker found statistically significant associations; orange: part of the studies found statistically significant and part found statistically nonsignificant (NS) associations; pink: all studies found statistically NS associations. The overall (OS) and disease-free survival (DFS) is presented for patients with a positive (+) and a negative () marker. # = no percentage of patients or median or mean OS or DFS provided, * = median, ** = mean. TNM = tumor (T), nodes (N), and metastases (M).